Advisor Net Financial, Inc Novavax Inc Transaction History

Advisor Net Financial, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$69.73 - $142.9 $1,185 - $2,429	-17 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$134.56 - $217.97 $2,287 - $3,705	17 New	17 $2,000
Q2 2021 Jul 06, 2021	SELL	$121.0 - $257.67 $2,420 - $5,153	-20 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$112.98 - $319.93 $2,259 - $6,398	20 New	20 $4,000
Q2 2020 Aug 26, 2020	SELL	$13.86 - $83.61 $9,507 - $57,356	-686 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $2,695 - $10,976	686 New	686 $9,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.